Aktienanalyse wird geladen …
LIN · NASDAQ · Specialty Chemicals · Großbritannien
468,02 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 33,99 Mrd. | 6,9 Mrd. | 14,61 $ | 472,2 Mio. | 0,4 Mio · 0,1 % | 10,2 Mio · 2,2 % | 48,8 % | 20,3 % | 10,78 $ | 0,35 $ | 6,00 $ |
| 2024 | 33,01 Mrd. | 6,57 Mrd. | 13,62 $ | 482,09 Mio. | 0,3 Mio · 0,1 % | 10,5 Mio · 2,2 % | 48,1 % | 19,9 % | 10,22 $ | 0,33 $ | 5,56 $ |
| 2023 | 32,85 Mrd. | 6,2 Mrd. | 12,59 $ | 492,29 Mio. | 0,3 Mio · 0,1 % | 12 Mio · 2,4 % | 46,8 % | 18,9 % | 11,21 $ | 0,29 $ | 5,10 $ |
| 2022 | 33,36 Mrd. | 4,15 Mrd. | 8,23 $ | 504,04 Mio. | 0,2 Mio · 0 % | 18,1 Mio · 3,6 % | 41,7 % | 12,4 % | 11,29 $ | 0,21 $ | 4,68 $ |
| 2021 | 30,79 Mrd. | 3,83 Mrd. | 7,33 $ | 521,88 Mio. | 0,3 Mio · 0,1 % | 9,6 Mio · 1,8 % | 43 % | 12,4 % | 12,72 $ | 0,25 $ | 4,24 $ |
| 2020 | 27,24 Mrd. | 2,5 Mrd. | 4,71 $ | 531,16 Mio. | 0,3 Mio · 0,1 % | 14,3 Mio · 2,7 % | 43,5 % | 9,2 % | 7,59 $ | 0,25 $ | 3,85 $ |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|
| Q2 2026 | 9,29 Mrd. | 1,93 Mrd. | 4,15 $ | 464,52 Mio. | 20,8 % | 1,79 $ |
| Q1 2026 | 8,78 Mrd. | 1,86 Mrd. | 3,98 $ | 466,32 Mio. | 21,2 % | 1,93 $ |
| Q4 2025 | 8,76 Mrd. | 1,53 Mrd. | 3,24 $ | 468,7 Mio. | 17,5 % | 3,33 $ |
| Q3 2025 | 8,62 Mrd. | 1,93 Mrd. | 4,09 $ | 471,51 Mio. | 22,4 % | 3,55 $ |
| Q2 2025 | 8,5 Mrd. | 1,77 Mrd. | 3,73 $ | 473,57 Mio. | 20,8 % | 2,01 $ |
| Q1 2025 | 8,11 Mrd. | 1,67 Mrd. | 3,51 $ | 476,26 Mio. | 20,6 % | 1,87 $ |
| Q4 2024 | 8,28 Mrd. | 1,73 Mrd. | 3,65 $ | — | 20,8 % | 3,30 $ |
| Q3 2024 | 8,36 Mrd. | 1,55 Mrd. | 3,22 $ | 480,9 Mio. | 18,6 % | 3,46 $ |
Linde (LIN) Draws Valuation Attention, Is The Premium Already Too Rich?
The Zacks Analyst Blog Highlights AMD, Linde, Amgen and INNOVATE
Top Research Reports for AMD, Linde & Amgen
‘Unique Opportunity’: Analyst Says Industrial Giant Wins ‘Lion’s Share’ of AI Chip Contracts at a ‘Mundane Defensive Valuation’
Billionaire Daniel Sundheim’s 2 New Non-AI Stock Picks
Linde Poised to Resume 10%-Plus EPS Growth in 2027, Deutsche Bank Says
Linde plc is a global industrial gases and engineering company that supplies essential gases, technologies, and services to a wide range of industries. Its core product lineup includes atmospheric gases such as oxygen, nitrogen, and argon, along with process gases including hydrogen, helium, carbon dioxide, and specialty gases used in manufacturing and high-precision applications. The company also designs and builds industrial gas plants and related process equipment, supporting customers with on-site supply, gas processing, and engineering solutions. Linde serves sectors such as healthcare, chemicals and energy, food and beverage, electronics, metals and mining, and general manufacturing, where its products are used as critical inputs in production and operations. Through its industrial gases and engineering businesses, Linde plays a central role in supplying infrastructure that supports everyday industrial activity across global markets.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest LIN und jede andere Aktie unbegrenzt.